SYSTEMATIC REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Pharmacological Effects and Mechanisms of Curcumin in Animal Models of Parkinson's Disease: A Systematic Review and Meta-Analysis
Provisionally accepted
- 1Changchun University of Chinese Medicine, Changchun, China
- 2Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Curcumin has been demonstrated to possess promising neuroprotective potential in Parkinson's disease; however, its overall effects remain inconclusive, and its multiple mechanisms of action have not been systematically summarized. Objective This systematic review and meta-analysis aimed to evaluate the pharmacological effects of curcumin in animal models of Parkinson's disease and to investigate its potential mechanisms involving antioxidant, anti-inflammatory, and neuroprotective effects, thereby providing a theoretical basis for its potential clinical application in Parkinson's disease. Methods A comprehensive search of four databases (EMBASE, PubMed, Web of Science, and the Cochrane Library) up to August 2025 identified 31 eligible studies involving a total of 552 animals. Methodological quality was assessed using the SYRCLE risk of bias tool. Standardized mean differences (SMDs) were calculated to evaluate the effects of curcumin on motor function, neurochemistry, inflammation, and oxidative stress in animal models of Parkinson's disease. Results The results demonstrated that curcumin intervention improved motor function in animal models of Parkinson's disease, as evidenced by increased locomotor distance in the open field test (SMD = 1.25) and elevated mean velocity (SMD = 1.42), prolonged latency to fall in the rotarod test (SMD = 2.49), shortened descent time in the pole test (SMD = −1.16), and reduced traversal time on the balance beam (SMD = −2.27). Curcumin exhibited neuroprotective effects through increasing the number of tyrosine hydroxylase-positive cells (SMD = 2.12), maintaining dopamine levels (SMD = 4.11), and elevating 3,4-dihydroxyphenylacetic acid concentrations (SMD = 3.15). Regarding anti-inflammatory effects, curcumin significantly reduced multiple inflammatory markers, including interleukin-6 (SMD = −4.73), interleukin-1β (SMD = −3.30), tumor necrosis factor-α (SMD = −3.19), and nitric oxide (SMD = −4.91). With respect to antioxidant activity, curcumin significantly reduced malondialdehyde levels (SMD = −4.69) while increasing the activities of superoxide dismutase (SMD = 3.90), glutathione (SMD = 2.08), and catalase (SMD = 2.00). Conclusion Curcumin demonstrates significant neuroprotective effects in Parkinson's disease animal models, improving motor deficits and neuronal integrity likely through multi-target mechanisms involving anti-inflammatory and antioxidant pathways.
Keywords: Animal Models, Curcumin, mechanisms, Parkinson's disease, systematic review and meta-analysis
Received: 03 Jan 2026; Accepted: 05 Feb 2026.
Copyright: © 2026 Pang, Fu, He, Guo and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ge Yang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.